Olink®Part of Thermo Fisher Scientific
Powerful, NGS-based proteomics - effortlessly uncover meaningful insights
A unique combination of specificity and scalability enables high-throughput, multiplex protein biomarker analysis.
Next-generation high-throughput proteomics empowers genetically-informed assessment of protein causality and the confident identification of novel drug targets.
Join the growing global community and consortia of Olink users to empower your biomarker discovery.
Over 3,800 and growing rapidly – covering all major disease areas
Your source for Olink’s terms, privacy policies, and compliance details
Filters
Cancers, 2022Type 2 Diabetes-Related Variants Influence the Risk of Developing Prostate Cancer: A Population-Based Case-Control Study and Meta-Analysis
Sánchez-Maldonado J., Collado R., Cabrera-Serrano A. et al.
Olink Target 96
Frontiers in Immunology, 2022The Genetic Risk for COVID-19 Severity Is Associated With Defective Immune Responses
Kuijpers Y., Chu X., Jaeger M. et al.
Nature Communications, 2022Genetic analyses identify pleiotropy and causality for blood proteins and highlight Wnt/β-catenin signalling in migraine
Tanha H., Nyholt D., Nyholt D.,
Clinical and Translational Medicine, 2022Proteomic profiling of lung diffusion impairment in the recovery stage of SARS‐CoV‐2–induced ARDS
García‐Hidalgo M., González J., Benítez I. et al.
mBio, 2022Serine Protease Inhibitors Restrict Host Susceptibility to SARS-CoV-2 Infections
Rosendal E., Mihai I., Becker M. et al.
Olink Target 48
Nature Communications, 2022Contribution of rare whole-genome sequencing variants to plasma protein levels and the missing heritability
Kierczak M., Rafati N., Höglund J. et al.
Scandinavian Journal of Pain, 2022Association between systemic inflammation and experimental pain sensitivity in subjects with pain and painless neuropathy after traumatic nerve injuries
Miclescu A., Granlund P., Butler S. et al.
The Journal of Infectious Diseases, 2022Proteomic Signature of Subclinical Coronary Artery Disease in People With HIV: Analysis of the REPRIEVE Mechanistic Substudy
Kolossváry M., deFilippi C., Lu M. et al.
Journal of Cardiovascular Translational Research, 2022Investigation into the Health Effects of Reduced Chymase Function Using Predicted Loss-of-Function Mutations in CMA1
Fairhurst-Hunter Z., Walters R., Zink A. et al.
Communications Biology, 2022Immunofibroblasts regulate LTα3 expression in tertiary lymphoid structures in a pathway dependent on ICOS/ICOSL interaction
Nayar S., Pontarini E., Campos J. et al.
Cell Reports Medicine, 2022TNF-α+ CD4+ T cells dominate the SARS-CoV-2 specific T cell response in COVID-19 outpatients and are associated with durable antibodies
van der Ploeg K., Kirosingh A., Mori D. et al.
Proteomes, 2022Insights on Proteomics-Driven Body Fluid-Based Biomarkers of Cervical Cancer
Mukherjee A., Pednekar C., Kolke S. et al.
PROTEOMICS – Clinical Applications, 2022Clinical applications of plasma proteomics and peptidomics: Towards precision medicine
He B., Huang Z., Huang C. et al.
Molecular Metabolism, 2022Gene-based whole genome sequencing meta-analysis of 250 circulating proteins in three isolated European populations
Gilly A., Klaric L., Park Y. et al.
Biochemical and Biophysical Research Communications, 2022A pilot study using proximity extension assay of cerebrospinal fluid and its extracellular vesicles identifies novel amyotrophic lateral sclerosis biomarker candidates
Sjoqvist S., Otake K.
Cell, 2022Cannabinoid receptor 1 antagonist genistein attenuates marijuana-induced vascular inflammation
Wei T., Chandy M., Nishiga M. et al.
American Journal of Respiratory Cell and Molecular Biology, 2022Peripheral Blood Inflammation Profile of Patients with Pulmonary Arterial Hypertension Using the High-Throughput Olink Proteomics Platform
Mickael C., Kheyfets V., Langouët-Astrié C. et al.
Translational Psychiatry, 2022Metabolomics analysis of post-traumatic stress disorder symptoms in World Trade Center responders
Kuan P., Yang X., Kotov R. et al.
Frontiers in Aging Neuroscience, 2022The Roles of Long-Term Hyperhomocysteinemia and Micronutrient Supplementation in the AppNL–G–F Model of Alzheimer’s Disease
Nieraad H., de Bruin N., Arne O. et al.
Olink Target 96 Mouse
Experimental Dermatology, 2022Ustekinumab reduces serum protein levels associated with cardiovascular risk in psoriasis vulgaris
Koschitzky M., Navrazhina K., Garshick M. et al.
3874 publications
Items per page
2981-3000 of 3874 publications